Balaxi Pharmaceuticals Ltd. Stock Analysis BALAXI.NS

Balaxi Pharmaceuticals Ltd. is an intellectual property rights-based pharmaceutical company, which engages in the provision of business of international wholesale trading of pharmaceuticals, builders' hardware, and fast-moving consumer goods products. The firm operates as an intellectual property right (IPR)-based pharmaceutical company. The firm primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The firm is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. The company is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.